Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment-Reference-Cited by-同舟云学术

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment

Published:2011-01 Issue:1 Volume:120 Page:23-28
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Aletti Giovanni D.,Eisenhauer Eric L.,Santillan Antonio,Axtell Allison,Aletti Giacomo,Holschneider Christine,Chi Dennis S.,Bristow Robert E.,Cliby William A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference24 articles.

1. Ovarian cancer. Clinical practice guidelines in oncology;Morgan;J Nettl Compr Canc Netw,2008

2. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma;Griffiths;Natl Cancer Inst Monogr,1975

3. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J Clin Oncol,2002

4. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study;Eisenkop;Gynecol Oncol,1998

5. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach;Chi;Gynecol Oncol,2004

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial);Journal of Ovarian Research;2024-07-12

2. Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer;PLOS ONE;2024-05-28

3. Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study;Frontiers in Oncology;2024-05-28

4. Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role;European Journal of Surgical Oncology;2024-04

5. Significance of Pretreatment Hemoglobin-Albumin-Lymphocyte-Platelet Index for the Prediction of Suboptimal Surgery in Epithelial Ovarian Cancer;World Journal of Oncology;2024-04